$ARQQ

Nilan Nicholas William sold $12K of ARQQ

Nilan Nicholas William (General Manager-US) sold 494 shares of Arqit Quantum Inc. (ARQQ) at $24.47 on 2026-10-02.

Original reporting
SEC EDGAR · Nilan Nicholas William
Published Oct 6, 2026, 11:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ARQQ
Bearish
medium confidence
Mentioned
$ARQQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARQQBearishLow
01

Why it matters

A modest insider sell may create slight short‑term pressure but unlikely to move the stock materially.

02

Market read

Primary disclosure of a small insider sale; limited trading relevance.

03

What to watch

No material change in company fundamentals; the insider remains a large holder.

Relevance 3/10Novelty 3/10Timing: post-market filing

Background

SEC Form 4 filing discloses an insider's open‑market sale of ARQQ shares.

Company-level read

Ticker impact

$ARQQBearishMedium confidence
Context

Form 4 shows General Manager sold 494 shares for $12,090, reducing holdings to 466 shares.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

The sale is small but recent; investors often view insider sells as a modest bearish cue.

Market effects

Minimal impact on quantum‑tech sector; only a single insider transaction.

None

None

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • Arqit Quantum Inc.

    Quantum communications firm listed on Nasdaq under ARQQ.

  • Nilan Nicholas William

    General Manager‑US and officer of Arqit Quantum.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$QNTMedAI 9/10

Quantum Computing Shares Sink Ahead Of Blockbuster Quantinuum IPO

Quantinuum (QNT) shares fell Wednesday as the Honeywell-backed firm neared its Nasdaq debut, with pricing set for June 3 and first trading expected June 4. The company plans to sell 26.5 million shares at $53–$55 to raise about $1.46 billion, valuing it at up to $14.3 billion, according to the report. Other quantum stocks also declined.

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).